Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MDT Stock Forecast 2026-2027
$80.69
Current Price
$103.60B
Market Cap
Buy 18
Hold 12
Sell 0
Wall St Analyst Ratings
Distance to MDT Price Targets
+50.0%
To High Target of $121.00
+24.6%
To Median Target of $100.50
-3.3%
To Low Target of $78.00
MDT Price Momentum
+9.4%
1 Week Change
+6.0%
1 Month Change
-7.7%
1 Year Change
-16.0%
Year-to-Date Change
-24.1%
From 52W High of $106.33
+10.1%
From 52W Low of $73.31
📊 TOP ANALYST CALLS
Did MDT Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Medtronic is one of their latest high-conviction picks.
Latest MDT Stock Price Targets & Analyst Predictions
Based on our analysis of 15 Wall Street analysts, MDT has a bullish consensus with a median price target of $100.50 (ranging from $78.00 to $121.00). The overall analyst rating is Strong Buy (8.2/10). Currently trading at $80.69, the median forecast implies a 24.6% upside. This outlook is supported by 18 Buy, 12 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MDT Analyst Ratings
18
Buy
12
Hold
0
Sell
MDT Price Target Range
Low
$78.00
Average
$100.50
High
$121.00
Current: $80.69
Latest MDT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MDT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 5, 2026 | Goldman Sachs | David Roman | Neutral | Maintains | $83.00 |
| Jun 5, 2026 | Bernstein | Lee Hambright | Outperform | Maintains | $97.00 |
| Jun 4, 2026 | UBS | Priya Sachdeva | Neutral | Maintains | $85.00 |
| Jun 4, 2026 | TD Cowen | Joshua Jennings | Buy | Reiterates | $119.00 |
| Jun 4, 2026 | RBC Capital | Shagun Singh | Outperform | Reiterates | $118.00 |
| Jun 4, 2026 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $102.00 |
| Jun 4, 2026 | Leerink Partners | Mike Kratky | Outperform | Maintains | $104.00 |
| Jun 4, 2026 | Baird | David Rescott | Neutral | Maintains | $85.00 |
| Jun 4, 2026 | BTIG | Ryan Zimmerman | Buy | Upgrade | $90.00 |
| Jun 3, 2026 | Mizuho | Anthony Petrone | Outperform | Maintains | $100.00 |
| Jun 3, 2026 | Needham | Mike Matson | Buy | Maintains | $101.00 |
| Apr 22, 2026 | UBS | Neutral | Maintains | $N/A | |
| Apr 15, 2026 | Truist Securities | Hold | Maintains | $N/A | |
| Apr 13, 2026 | Mizuho | Outperform | Maintains | $N/A | |
| Apr 9, 2026 | Evercore ISI Group | Outperform | Maintains | $N/A | |
| Apr 7, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Apr 6, 2026 | Evercore ISI Group | Outperform | Maintains | $N/A | |
| Apr 6, 2026 | Argus Research | Buy | Maintains | $N/A | |
| Apr 1, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Apr 1, 2026 | Piper Sandler | Neutral | Maintains | $N/A |
Medtronic plc (MDT) Competitors
The following stocks are similar to Medtronic based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Medtronic plc (MDT) Financial Data
Medtronic plc has a market capitalization of $103.60B with a P/E ratio of 21.9x. The company generates $36.36B in trailing twelve-month revenue with a 13.2% profit margin.
Revenue growth is +9.9% quarter-over-quarter, while maintaining an operating margin of +21.3% and return on equity of +9.9%.
Valuation Metrics
Market Cap
$103.60B
Enterprise Value
$124.75B
P/E Ratio
21.9x
PEG Ratio
1.2x
Price/Sales
2.9x
Growth & Margins
Revenue Growth (YoY)
+9.9%
Gross Margin
N/A
Operating Margin
+21.3%
Net Margin
+13.2%
EPS Growth
+17.7%
Financial Health
Cash/Price Ratio
+8.1%
Current Ratio
2.5x
Debt/Equity
57.1x
ROE
+9.9%
ROA
+5.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Medtronic plc (MDT) Business Model
About Medtronic plc
What They Do
Develops medical technology and therapies.
Business Model
Medtronic generates revenue by designing, manufacturing, and selling a diverse range of medical devices and therapies targeted at various health conditions. The company operates through four key segments, each focusing on specific medical needs, allowing it to cater to a broad customer base including hospitals, clinics, and healthcare professionals worldwide.
Additional Information
Founded in 1949 and headquartered in Dublin, Ireland, Medtronic has a global footprint, serving markets in the United States, Europe, Japan, and beyond. The company is committed to advancing healthcare technology, providing innovative solutions that enhance patient care and improve outcomes.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
95,000
CEO
Mr. Geoffrey Straub Martha
Country
Ireland
IPO Year
1981
Website
www.medtronic.comMedtronic plc (MDT) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
ISRG Falls 11% in a Month: Is a Reversal on the Cards for the Stock?
Intuitive Surgical falls 11% in a month despite strong revenues, procedure growth and da Vinci 5 adoption, raising questions about a potential rebound.
Jun 03, 2026
By Indrajit Bandyopadhyay
Analyst Blog
Private Payrolls Increased More Than Expected
Private Payrolls Increased More Than Expected
Jun 03, 2026
By Zacks Equity Research
Economic Highlights
Medtronic Q4 Earnings and Revenues Beat, Stock Rises in Pre-Market
MDT tops Q4 revenue and earnings estimates as Cardiovascular strength and Cardiac Ablation growth fuel results, while FY27 guidance points higher.
Jun 03, 2026
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
Wall Street analysts' recommendations influence investor decisions and can impact stock prices, but the actual significance of these ratings is questioned.
Why It Matters
Wall Street analyst ratings influence stock prices, shaping investor sentiment and trading decisions, which can lead to volatility and impact market trends.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Lowe's, Medtronic, and UnitedHealth Group are noted for strong dividend growth, providing above-average payouts with attractive valuations for investors.
Why It Matters
Solid dividend growth stocks like Lowe's, Medtronic, and UnitedHealth Group provide reliable income and potential capital appreciation, appealing to income-focused and value-oriented investors.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Low-volatility stocks are outperforming the market on a risk-adjusted basis, providing investors with a more stable investment experience.
Why It Matters
Low-volatility stocks outperforming the market on a risk-adjusted basis can attract investors seeking stability and reduced risk, potentially shifting capital away from more volatile options.
Source: Market Watch
Market Sentiment:
Positive
Quick Summary
Medtronic exceeded Wall Street's expectations for Q4 revenue and adjusted profit, driven by strong demand for its heart devices in complex cardiac procedures.
Why It Matters
Medtronic's strong Q4 performance indicates robust demand for its heart devices, suggesting potential growth and stability, which can positively influence investor sentiment and stock performance.
Source: Reuters
Market Sentiment:
Positive
Medtronic Q4 Earnings Call Highlights
6 days ago
Quick Summary
Medtronic (NYSE: MDT) reported its strongest top-line performance in a decade, with growth in cardiac ablation, diabetes, medical-surgical products, and neuroscience, exceeding fiscal Q4 and full-year expectations.
Why It Matters
Medtronic's strong performance signals robust demand in key sectors, potentially boosting investor confidence and stock value, indicating positive growth prospects ahead.
Source: MarketBeat
Market Sentiment:
Positive
Medtronic Posts Higher Profit, Sales
6 days ago
Quick Summary
Medtronic reported increased profit and sales in its fiscal fourth quarter, indicating successful measures to enhance business performance and growth.
Why It Matters
Medtronic's profit and sales increase indicates improved business performance, potentially boosting investor confidence and stock value as growth prospects strengthen.
Source: WSJ
Market Sentiment:
Positive
Frequently Asked Questions About MDT Stock
What is Medtronic plc's (MDT) stock forecast for 2026?
Based on our analysis of 15 Wall Street analysts, Medtronic plc (MDT) has a median price target of $100.50. The highest price target is $121.00 and the lowest is $78.00.
Is MDT stock a good investment in 2026?
According to current analyst ratings, MDT has 18 Buy ratings, 12 Hold ratings, and 0 Sell ratings. The stock is currently trading at $80.69. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MDT stock?
Wall Street analysts predict MDT stock could reach $100.50 in the next 12 months. This represents a 24.6% increase from the current price of $80.69. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Medtronic plc's business model?
Medtronic generates revenue by designing, manufacturing, and selling a diverse range of medical devices and therapies targeted at various health conditions. The company operates through four key segments, each focusing on specific medical needs, allowing it to cater to a broad customer base including hospitals, clinics, and healthcare professionals worldwide.
What is the highest forecasted price for MDT Medtronic plc?
The highest price target for MDT is $121.00 from at , which represents a 50.0% increase from the current price of $80.69.
What is the lowest forecasted price for MDT Medtronic plc?
The lowest price target for MDT is $78.00 from at , which represents a -3.3% decrease from the current price of $80.69.
What is the overall MDT consensus from analysts for Medtronic plc?
The overall analyst consensus for MDT is bullish. Out of 15 Wall Street analysts, 18 rate it as Buy, 12 as Hold, and 0 as Sell, with a median price target of $100.50.
How accurate are MDT stock price projections?
Stock price projections, including those for Medtronic plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 9, 2026 3:16 AM UTC